These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30971125)

  • 1. Ethnic access to child-parent screening for familial hypercholesterolaemia.
    Wald DS; Bestwick JP
    Eur J Prev Cardiol; 2019 Aug; 26(12):1341-1342. PubMed ID: 30971125
    [No Abstract]   [Full Text] [Related]  

  • 2. Integration of child-parent screening and cascade testing for familial hypercholesterolaemia.
    Wald DS; Wald NJ
    J Med Screen; 2019 Jun; 26(2):71-75. PubMed ID: 30319009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The UK National Screening Committee's position on child-parent screening for familial hypercholesterolaemia.
    Wald DS; Neely D
    J Med Screen; 2021 Sep; 28(3):217-220. PubMed ID: 34292841
    [No Abstract]   [Full Text] [Related]  

  • 4. Child-parent screening for familial hypercholesterolemia.
    Wald DS; Kasturiratne A; Godoy A; Ma L; Bestwick JP; Brewer N; Wald NJ
    J Pediatr; 2011 Nov; 159(5):865-7. PubMed ID: 21798558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis.
    Warner M
    Ann Clin Biochem; 2008 Jan; 45(Pt 1):114. PubMed ID: 18275690
    [No Abstract]   [Full Text] [Related]  

  • 6. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
    Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL
    Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal screening of children for familial hypercholesterolaemia: Value for money?
    Ademi Z; Martin AC
    Atherosclerosis; 2018 Aug; 275():384-386. PubMed ID: 29961599
    [No Abstract]   [Full Text] [Related]  

  • 8. Cascade screening of familial hypercholesterolemia must go on.
    Galema-Boers JM; Versmissen J; Roeters van Lennep HW; Dusault-Wijkstra JE; Williams M; Roeters van Lennep JE
    Atherosclerosis; 2015 Oct; 242(2):415-7. PubMed ID: 26282946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parental attitude towards genetic testing for familial hypercholesterolaemia in children.
    Umans-Eckenhausen MA; Oort FJ; Ferenschild KC; Defesche JC; Kastelein JJ; de Haes JC
    J Med Genet; 2002 Sep; 39(9):e49. PubMed ID: 12205119
    [No Abstract]   [Full Text] [Related]  

  • 10. Landmark position paper on paediatric familial hypercholesterolaemia from the EAS Consensus Panel.
    Stock J
    Atherosclerosis; 2015 Sep; 242(1):277-80. PubMed ID: 26232168
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening children at immunisation visits can identify familial hypercholesterolaemia.
    Mayor S
    BMJ; 2016 Oct; 355():i5794. PubMed ID: 27789464
    [No Abstract]   [Full Text] [Related]  

  • 12. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
    Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
    Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    Wald DS; Bestwick JP; Morris JK; Whyte K; Jenkins L; Wald NJ
    N Engl J Med; 2016 Oct; 375(17):1628-1637. PubMed ID: 27783906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies.
    Wald DS; Bestwick JP
    Atherosclerosis; 2020 Jan; 293():57-61. PubMed ID: 31837509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis.
    McKay AJ; Hogan H; Humphries SE; Marks D; Ray KK; Miners A
    Atherosclerosis; 2018 Aug; 275():434-443. PubMed ID: 29937236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
    Watts GF; Gidding S; Wierzbicki AS; Toth PP; Alonso R; Brown WV; Bruckert E; Defesche J; Lin KK; Livingston M; Mata P; Parhofer KG; Raal FJ; Santos RD; Sijbrands EJ; Simpson WG; Sullivan DR; Susekov AV; Tomlinson B; Wiegman A; Yamashita S; Kastelein JJ;
    Eur J Prev Cardiol; 2015 Jul; 22(7):849-54. PubMed ID: 24776375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France.
    Bruckert E; Kalmykova O; Bittar R; Carreau V; Béliard S; Saheb S; Rosenbaum D; Bonnefont-Rousselot D; Thomas D; Emery C; Khoshnood B; Carrié A
    Atherosclerosis; 2017 Feb; 257():130-137. PubMed ID: 28131047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies.
    Martin AC; Bell DA; Brett T; Watts GF
    Curr Opin Lipidol; 2017 Aug; 28(4):321-327. PubMed ID: 28426524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision to reject screening for familial hypercholesterolaemia is flawed.
    Wald DS; Martin AC
    Arch Dis Child; 2021 Jun; 106(6):525-526. PubMed ID: 32601084
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part.
    Brett T; Qureshi N; Gidding S; Watts GF
    Atherosclerosis; 2018 Oct; 277():399-406. PubMed ID: 30270077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.